首页> 外文期刊>Endocrine journal >Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity
【24h】

Structure and function analysis of adiponectin receptors toward development of novel antidiabetic agents promoting healthy longevity

机译:脂联素受体的结构和功能分析对促进健康长寿的新型抗糖尿病药的发展

获取原文
           

摘要

Plasma adiponectin levels and expression of its receptors, AdipoRs are decreased in obesity, which cause insulin resistance and diabetes. AdipoR-deficient mice exhibit insulin resistance and impaired glucose tolerance. Moreover, newly identified AdipoR agonists not only improve insulin resistance but prolong lifespan shortened by obesity via AdipoR. Furthermore, efforts to promote structure-based drug discovery research at our laboratory have led to the first ever successful crystallization of AdipoR as well as to clarification of their structures. Structural analysis of AdipoRs as key molecules in lifestyle-related diseases is thus expected to lead not only to the acceleration of structure-based drug discovery but to the elucidation of novel aspects of the AdipoR structures and functions in the years to come. Finally, with the development of novel AdipoR-targeted antidiabetic agents also capable of prolonging lifespan, the attainment of healthy longevity may finally be brought within reach.
机译:肥胖者血浆脂联素水平及其受体,AdipoRs的表达降低,从而引起胰岛素抵抗和糖尿病。 AdipoR缺陷型小鼠表现出胰岛素抵抗和葡萄糖耐量受损。此外,新发现的AdipoR激动剂不仅可以改善胰岛素抵抗,而且可以通过AdipoR减轻肥胖导致的寿命缩短。此外,在我们实验室促进基于结构的药物发现研究的努力已导致AdipoR的首次成功结晶以及其结构的阐明。因此,预期作为生活相关疾病中关键分子的AdipoR的结构分析将不仅导致基于结构的药物发现的加速,而且将在未来几年阐明AdipoR结构和功能的新颖方面。最后,随着也能够延长寿命的新型靶向AdipoR的抗糖尿病药的开发,最终可以实现健康长寿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号